The diverse trajectories of bacterial heterogeneity and adapted subpopulations in invasive Staphylococcus aureus infections

Bacteria are not static invaders; they are dynamic, evolving communities that change as they fight to survive inside the human body. When a person develops a severe infection with Staphylococcus aureus, a common and often dangerous bacterium, doctors treat it with antibiotics. However, the treatment does not always work. Sometimes the infection lingers or returns, a phenomenon known as treatment failure. For years, scientists have suspected that this happens because the bacteria evolve resistance or learn to hide from the immune system while inside the patient. But a critical question remained unanswered: do these dangerous changes happen in a single, dominant group of bacteria that takes over the entire infection, or do they exist as small, hidden subgroups that never fully take control? Understanding this distinction is vital because it changes how we might think about why treatments fail and how we could potentially track these invisible threats.

To answer this, a team of researchers led by Stefano Giulieri and Benjamin Howden launched a massive, detailed study called BARISTA. They followed 103 patients in Australia who were hospitalized with invasive S. aureus infections, meaning the bacteria had entered sterile parts of the body like the blood or joints. Instead of just taking a single sample from a patient and sequencing one colony of bacteria, as was common in the past, the researchers collected hundreds of samples over time. Crucially, they grew up to five separate bacterial colonies from each sample and sequenced the genetic code of each one individually. This approach allowed them to see the genetic diversity within a single patient's infection, looking for small differences between the bacteria that might be hiding in plain sight.

The researchers found that the bacteria living in a patient's nose were much more genetically diverse than those causing the actual infection in the blood or other sterile sites. This makes sense, as the nose is a long-term home for the bacteria, allowing more time for variety to develop. However, the study revealed something surprising about the infections themselves. While most infections were caused by a single, uniform group of bacteria, a significant number of patients showed signs of genetic diversity within their sterile-site infections. This meant that even in a severe, invasive infection, the bacterial population was not always a single, cloned army, but could contain a mix of different genetic variants.

The team then looked for specific genetic changes that the bacteria had acquired to survive the infection, such as mutations that help them resist antibiotics or evade the immune system. They identified 16 genes where these helpful changes appeared repeatedly across different patients. One of the most common changes occurred in a gene called agrA, which controls how the bacteria communicate and cause disease. Another significant finding involved a gene called adh1, which had not been previously linked to this kind of adaptation. The presence of these mutations in patients whose infections were difficult to treat suggests that these genetic changes are indeed part of the problem.

Perhaps the most important discovery concerned how these adapted bacteria behave over time. The researchers had hypothesized that a beneficial mutation would start as a tiny, rare variant and then sweep through the entire bacterial population, becoming the dominant type as the infection progressed. This is known as a selective sweep. While they did find some examples of this happening, the majority of the time, the adapted bacteria did not take over. Instead, the mutations remained at low frequencies, existing as small subpopulations that never became dominant. Even in cases where the bacteria had acquired a mutation that should have helped them survive, they often stayed in the minority. This suggests that the environment inside a human infection is complex and constantly changing, preventing any single bacterial variant from completely taking charge.

The study also examined a different type of genetic change called insertion sequences, which are pieces of DNA that can jump around the bacterial genome. While these were known to play a role in other bacteria, the researchers found that in S. aureus infections, these jumping genes were rare and did not seem to drive the bacteria's adaptation in the same way that simple point mutations did.

Ultimately, this research changes the picture of how S. aureus infections evolve. It shows that the bacteria do not always follow a simple path of one group taking over. Instead, they often maintain a diverse mix of variants, with some carrying helpful mutations that stay hidden at low levels. This means that standard tests, which usually look at just one or a few bacteria, might miss these dangerous, adapted subgroups entirely. By revealing that the bacteria can adapt without ever becoming the dominant type, the study suggests that treatment failure might be driven by these elusive, low-frequency populations that standard methods fail to detect. The findings highlight the need for more sensitive ways to look at infections, ensuring that doctors can see the full picture of the bacterial community they are trying to treat.